TipRanks
Advertisement
Advertisement

HK:2480 Stock Latest News

Beijing Luzhu Clarifies Limits on Share Awards and Equity-Linked Deals in 2025 Report
Company AnnouncementsBeijing Luzhu Clarifies Limits on Share Awards and Equity-Linked Deals in 2025 Report
11d ago
2480
Beijing Luzhu Biotechnology Publishes Unaudited Interim Results for First Half of 2026
PremiumCompany Announcements
Beijing Luzhu Biotechnology Publishes Unaudited Interim Results for First Half of 2026
1M ago
2480
Beijing Luzhu Biotechnology Sets Board Meeting to Review Interim Results
PremiumCompany Announcements
Beijing Luzhu Biotechnology Sets Board Meeting to Review Interim Results
2M ago
2480
Luzhu Biotech’s Herpes Zoster Vaccine LZ901 Shows Strong Phase III Results in China
PremiumCompany Announcements
Luzhu Biotech’s Herpes Zoster Vaccine LZ901 Shows Strong Phase III Results in China
2M ago
2480
Beijing Luzhu Biotechnology Consolidates Company Secretary and Governance Roles
PremiumCompany Announcements
Beijing Luzhu Biotechnology Consolidates Company Secretary and Governance Roles
4M ago
2480
Beijing Luzhu Calls 2026 AGM and Seeks Fresh Share Issuance Mandate
PremiumCompany AnnouncementsBeijing Luzhu Calls 2026 AGM and Seeks Fresh Share Issuance Mandate
5M ago
2480
Beijing Luzhu Reallocates IPO Proceeds to Core Vaccine Programs and Working Capital
Premium
Company Announcements
Beijing Luzhu Reallocates IPO Proceeds to Core Vaccine Programs and Working Capital
5M ago
2480
Luzhu Biotech Narrows 2025 Loss as Core Herpes Zoster Vaccine Nears Key Milestones
Premium
Company Announcements
Luzhu Biotech Narrows 2025 Loss as Core Herpes Zoster Vaccine Nears Key Milestones
7M ago
2480
Beijing Luzhu Biotechnology Revamps Key Company Secretarial and Governance Roles
PremiumCompany Announcements
Beijing Luzhu Biotechnology Revamps Key Company Secretarial and Governance Roles
7M ago
2480
Beijing Luzhu Biotechnology Sets March Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Beijing Luzhu Biotechnology Sets March Board Meeting to Approve 2025 Results
7M ago
2480
Beijing Luzhu Biotechnology Successfully Completes Phase I Trial of LZ901 in U.S.
PremiumCompany Announcements
Beijing Luzhu Biotechnology Successfully Completes Phase I Trial of LZ901 in U.S.
12M ago
2480
Beijing Luzhu Biotechnology Announces Board Composition
PremiumCompany Announcements
Beijing Luzhu Biotechnology Announces Board Composition
1y ago
2480
Beijing Luzhu Biotechnology Reports Reduced Losses and Milestones in H1 2025
PremiumCompany AnnouncementsBeijing Luzhu Biotechnology Reports Reduced Losses and Milestones in H1 2025
1y ago
2480
Beijing Luzhu Biotech Announces Positive Trial Results for LZ901 Vaccine
Premium
Company Announcements
Beijing Luzhu Biotech Announces Positive Trial Results for LZ901 Vaccine
1y ago
2480
Beijing Luzhu Biotechnology Schedules Board Meeting for Interim Results
Premium
Company Announcements
Beijing Luzhu Biotechnology Schedules Board Meeting for Interim Results
1y ago
2480
Beijing Luzhu Biotechnology Appoints New Lead Independent Director
PremiumCompany Announcements
Beijing Luzhu Biotechnology Appoints New Lead Independent Director
1y ago
2480
Beijing Luzhu Biotechnology Enhances Nomination Committee’s Role
PremiumCompany Announcements
Beijing Luzhu Biotechnology Enhances Nomination Committee’s Role
1y ago
2480
Beijing Luzhu Biotechnology Announces Board of Directors and Roles
PremiumCompany Announcements
Beijing Luzhu Biotechnology Announces Board of Directors and Roles
1y ago
2480
Beijing Luzhu Biotechnology Holds Successful AGM with Key Resolutions Passed
PremiumCompany Announcements
Beijing Luzhu Biotechnology Holds Successful AGM with Key Resolutions Passed
1y ago
2480
Beijing Luzhu Biotechnology Announces 2025 AGM with Key Resolutions
PremiumCompany AnnouncementsBeijing Luzhu Biotechnology Announces 2025 AGM with Key Resolutions
1y ago
2480
Beijing Luzhu Biotechnology Announces Board and Governance Changes
Premium
Company Announcements
Beijing Luzhu Biotechnology Announces Board and Governance Changes
1y ago
2480
Beijing Luzhu Biotechnology Reports 2024 Annual Results and Advances in R&D
Premium
Company Announcements
Beijing Luzhu Biotechnology Reports 2024 Annual Results and Advances in R&D
2y ago
2480

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >